INFLUENZA VACCINES MARKET ANALYSIS

Influenza Vaccines Market, By Vaccine Type (Inactivated, Live Attenuated), By Valency (Quadrivalent, Trivalent), By Route of Administration (Injection, Nasal Spray), By Age Group (Paediatrics, Adults), By Technology (Egg-Based Flu Vaccines, Cell Culture-Based Flu Vaccines, Recombinant Flu Vaccines), By Distribution Channel (Public, Private), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Mar 2024
Code : CMI1705
Pages :197
Formats :
Excel and PDF
Industry : Biotechnology

Market Challenges: High cost of vaccine development

High cost of vaccine development is expected to hinder growth of the market over the forecast period. For instance, on June 22, 2021, an article published in BMJ, a scientific journal stated about high costing higher prices vaccine The Centers for Disease Control and Prevention (CDC) purchased bulk vaccine through agreements for the 2020-21 flu season, the CDC purchased seven million doses directly from manufacturers for US$ 100m each a higher price than it has previous years

Market Opportunities: Initiatives taken by public health organizations

Public health organizations around the world have been taking significant initiatives to promote influenza vaccination, which can greatly benefit the influenza vaccines market. Various awareness campaigns and programs focused on educating people about the importance of annual flu shots have increased vaccination rates in recent years.